Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Molecular & Cellular Oncology|June 17, 2016
Pontin, a novel interactor of mutant p53 that promotes mutant p53 gain of functionYuhan Zhao, Xuetian Yue, Wenwei HuCancer Cell & Microenvironment|January 26, 2016
The regulation of leukemia inhibitory factorXuetian Yue, Lihua Wu, Wenwei HuJournal of Molecular Biology|April 10, 2017
Mutant p53 in Cancer: Accumulation, Gain-of-Function, and TherapyXuetian Yue, Yuhan Zhao, Yang Xu, et al.Oncotarget|December 31, 2015
Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 inductionXuetian Yue, Yuhan Zhao, Cen Zhang, et al.Cell Discovery|November 4, 2016
A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesisXuetian Yue, Yuhan Zhao, Grace Huang, et al.Cancer Cell International|February 13, 2022
ZHX2 inhibits thyroid cancer metastasis through transcriptional inhibition of S100A14Yankun Zhang, Min Sun, Lifen Gao, et al.The International Journal of Biochemistry & Cell Biology|September 9, 2014
Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinomaFang Luan, Peng Liu, Hongxin Ma, et al.Molecular Medicine Reports|September 26, 2013
Construction of a recombinant eukaryotic human ZHX1 gene expression plasmid and the role of ZHX1 in hepatocellular carcinomaJianping Wang, Dejie Liu, Xiaohong Liang, et al.Oncotarget|March 2, 2015
HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cellsLihua Wu, Haiyang Yu, Yuhan Zhao, et al.Cell Death & Disease|January 25, 2024
SHMT2 promotes papillary thyroid cancer metastasis through epigenetic activation of AKT signalingMin Sun, Mingjian Zhao, Ruowen Li, et al.Pageof 6